Arbutus Biopharma Corp ABUS:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/14/21 EDT
2.60quote price arrow down-0.02 (-0.76%)
Volume
3,068
Close
2.62quote price arrow up+0.12 (+4.80%)
Volume
711,569
52 week range
1.56 - 9.02

...

Loading . . .
  • Open2.57
  • Day High2.66
  • Day Low2.54
  • Prev Close2.50
  • 52 Week High9.02
  • 52 Week High Date07/24/20
  • 52 Week Low1.56
  • 52 Week Low Date05/14/20

Key Stats

  • Market Cap252.54M
  • Shares Out96.39M
  • 10 Day Average Volume1.69M
  • Dividend-
  • Dividend Yield-
  • Beta2.97
  • YTD % Change-26.2

KEY STATS

  • Open2.57
  • Day High2.66
  • Day Low2.54
  • Prev Close2.50
  • 52 Week High9.02
  • 52 Week High Date07/24/20
  • 52 Week Low1.56
  • 52 Week Low Date05/14/20
  • Market Cap252.54M
  • Shares Out96.39M
  • 10 Day Average Volume1.69M
  • Dividend-
  • Dividend Yield-
  • Beta2.97
  • YTD % Change-26.2

RATIOS/PROFITABILITY

  • EPS (TTM)-0.96
  • P/E (TTM)-2.72
  • Fwd P/E (NTM)-2.88
  • EBITDA (MRQ)-57.917M
  • ROE (MRQ)-3,450.29%
  • Revenue (MRQ)7.54M
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-879.31%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date08/02/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Arbutus Biopharma Corp

There is no recent news for this security.

Profile

MORE
Arbutus Biopharma Corporation is a clinical-stage biopharmaceutical company. The Company is engaged in discovering, developing and commercializing cure for people with chronic hepatitis B virus (HBV) infection. Its product pipeline is focused on finding curative combination regimen for chronic HBV infection, with the objective of developing a suite of products that intervene at different points in the viral life cycle and reactivate the host immune system. It is developing a...
Frank Torti M.D.
Chairman
William Collier
President
David Hastings
Chief Financial Officer
Elizabeth Howard Ph.D., J.D.
Executive Vice President
Address
701 Veterans Circle
Warminster, PA
18974
United States

Top Peers

SYMBOLLASTCHG%CHG
BLU
BELLUS Health Inc
3.64+0.19+5.51%
MDNA
Medicenna Therapeutics Corp
3.41+0.17+5.25%
IMV
IMV Inc
2.33+0.09+3.79%
ATE
DMAC
DiaMedica Therapeutics Inc
6.50+0.03+0.46%